Provider facility background
Gerald Falchook, MD

Gerald Falchook, MD

Medical Oncology
Dr. Gerald Falchook is the director of Sarah Cannon Research Institute at HealthONE, a clinical trials program which opened in 2014 in Denver for patients with advanced cancer. Dr. Falchook completed his oncology training at U.T. MD Anderson Cancer Center, where he also served as a faculty member for six years, developing investigator-initiated clinical trials, as well as collaborating with biotech industry partners to bring promising new drugs to cancer patients. Dr. Falchook has been the principal investigator or co-investigator of more than 200 clinical studies, including first-in-human studies and regimens that have received FDA approval. His research has been published extensively, including in the New England Journal of Medicine and The Lancet, with more than 140 publications in peer-reviewed journals, as well as more than 250 abstracts at national and international conferences.
Care Philosophy

Our goal is to help improve access to clinical trials here in Colorado, so that patients don’t have to travel far from home to get access to the most promising new treatments.

Cancer

Clinical Trials

Medical Oncology

Oncology